Open access
Open access
Powered by Google Translator Translator

Rheumatology

Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud’s phenomenon, and digital ulcers in patients with systemic sclerosis.

7 Oct, 2021 | 10:19h | UTC

Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud’s phenomenon, and digital ulcers in patients with systemic sclerosis – Rheumatology

 


The Dutch Multidisciplinary Occupational Health Guideline to Enhance Work Participation Among Low Back Pain and Lumbosacral Radicular Syndrome Patients.

7 Oct, 2021 | 10:18h | UTC

The Dutch Multidisciplinary Occupational Health Guideline to Enhance Work Participation Among Low Back Pain and Lumbosacral Radicular Syndrome Patients – Journal of Occupational Rehabilitation

 


Systematic Review: Is exercise an effective therapy to treat long-lasting low back pain?

3 Oct, 2021 | 22:32h | UTC

Summary: Is exercise an effective therapy to treat long-lasting low back pain? – Cochrane Library

Original Study: Exercise therapy for chronic low back pain – Cochrane Library

 

Commentary on Twitter

 


Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system—part V, knee.

23 Sep, 2021 | 09:59h | UTC

Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)—part V, knee – European Radiology

See other articles in the series: Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system.

 


AAOS Updates Clinical Practice Guideline for Osteoarthritis of the Knee.

21 Sep, 2021 | 09:03h | UTC

News release: AAOS Updates Clinical Practice Guideline for Osteoarthritis of the Knee – American Academy of Orthopaedic Surgeons

Guideline summary: Management of Osteoarthritis of the Knee (Non-Arthroplasty) (3rd Edition) – American Academy of Orthopaedic Surgeons

Full paper: Management of Osteoarthritis of the Knee (Non-Arthroplasty) Evidence-Based Clinical Practice Guideline

 


KDIGO 2021 clinical practice guideline for the management of glomerular diseases.

21 Sep, 2021 | 09:05h | UTC

KDIGO 2021 clinical practice guideline for the management of glomerular diseases – Kidney Disease: Improving Global Outcomes

Executive summary: KDIGO 2021 Guideline for the Management of Glomerular Diseases – Kidney Disease: Improving Global Outcomes

 


[Preprint] RCT: Additional heterologous vs. homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination.

9 Sep, 2021 | 09:55h | UTC

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial – medRxiv

 

Commentary on Twitter (thread – click for more)

 


Musculoskeletal complications following critical illness: A scoping review.

3 Sep, 2021 | 10:07h | UTC

Musculoskeletal complications following critical illness: A scoping review – Journal of Critical Care

 

Commentary on Twitter

 


Role of diagnostic imaging in psoriatic arthritis: how, when, and why.

3 Sep, 2021 | 10:05h | UTC

Role of diagnostic imaging in psoriatic arthritis: how, when, and why – Insights into Imaging

 


Review | COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses.

2 Sep, 2021 | 10:06h | UTC

COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses – The Lancet Rheumatology

 

Commentary on Twitter

 


Supplement: The future of JAK1 selective inhibitors in rheumatology.

26 Aug, 2021 | 08:30h | UTC

Homepage: The future of JAK1 selective inhibitors – Rheumatology

How important is JAK1 selectivity?

JAK1: Number one in the family; number one in inflammation?

Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis

Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis

The safety of JAK-1 inhibitors

Clinical use of Jak 1 inhibitors for rheumatoid arthritis

JAK1 selective inhibitors for the treatment of spondyloarthropathies

JAK1 inhibition and inflammatory bowel disease

 


ACOG Guideline: Osteoporosis prevention, screening, and diagnosis.

22 Aug, 2021 | 23:08h | UTC

Osteoporosis Prevention, Screening, and Diagnosis: ACOG Clinical Practice Guideline No. 1 – Obstetrics & Gynecology

 


FDA authorizes additional Covid-19 vaccine dose for certain immunocompromised individuals – Other fully vaccinated individuals do not need an additional vaccine dose right now.

16 Aug, 2021 | 01:22h | UTC

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals – U.S. Food & Drug Administration

Commentaries:

Statement on FDA Authorization of Supplemental Vaccine Dose for Immunocompromised Patients – Infectious Diseases Society of America

CDC, FDA recommend COVID booster for immune-compromised – CIDRAP

FDA authorizes additional dose of Covid-19 vaccine for the immunocompromised – STAT

The fine print: Understanding the new policy authorizing extra Covid vaccine doses for the immunocompromised – STAT

Covid booster: US approves third jab for the immunocompromised – BBC

CDC Committee Approves Third Covid-19 Shot For Immunocompromised People—Here’s Who Should Get One – Forbes

CDC Panel Recommends 3rd Vaccine Dose For Immunocompromised People – NPR

6 Things To Know If You’re Immunocompromised And Considering A 3rd Shot – NPR

CDC recommends third Covid-19 vaccine dose for certain immunocompromised people – CNN

 

Commentary on Twitter

 


Guideline: Acute abdomen in the immunocompromised patient.

16 Aug, 2021 | 01:00h | UTC

Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines – World Journal of Emergency Surgery

 


Guideline: Diagnosis and management of cutaneous lupus erythematosus – Classification, diagnosis, prevention, activity scores.

16 Aug, 2021 | 00:57h | UTC

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 1: Classification, diagnosis, prevention, activity scores – Journal of German Society of Dermatology

See also: S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics – Journal of German Society of Dermatology

 


Systematic review: Kinesio taping provides little or no benefit for rotator cuff disease.

16 Aug, 2021 | 00:52h | UTC

Kinesio taping for rotator cuff disease – Cochrane Library

Summary: Kinesio taping for rotator cuff disease – Cochrane Library

 

Commentary on Twitter

 


German S3-Guideline on the treatment of Psoriasis vulgaris.

13 Aug, 2021 | 09:45h | UTC

German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 1: Treatment goals and treatment recommendations – Journal of the German Society of Dermatology

 


Guideline: Diagnosis and management of cutaneous lupus erythematosus – Therapy, risk factors and other special topics.

12 Aug, 2021 | 08:55h | UTC

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics – Journal of German Society of Dermatology

 


Psoriasis: a brief overview.

12 Aug, 2021 | 08:39h | UTC

Psoriasis: a brief overview – Clinical Medicine Journal

 


M-A: Colchicine in patients with coronary artery disease – “colchicine reduces the risk of myocardial infarction and stroke, but has a higher rate of gastrointestinal upset with no influence on all‐cause mortality”.

8 Aug, 2021 | 23:40h | UTC

Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials – Journal of the American Heart Association

Related:

Review: Colchicine and the heart.

M-A: Colchicine administration for percutaneous coronary intervention

M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease

Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease

#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome

#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

#AHA19 – [Abstract Only] Practice Changing? – Randomized Trial: Low-Dose Colchicine Improves Outcomes after Myocardial Infarction

Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

 


Guideline summary: A Multidisciplinary collaborative approach to retinal toxic effects screening for patients taking antimalarials.

2 Aug, 2021 | 00:03h | UTC

A Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials – JAMA Dermatology (free for a limited period)

Original Guidance: Joint Statement: Hydroxychloroquine use with respect to retinal toxicity

 


Cohort study: Evidence of a potentially inappropriate and harmful prescribing cascade of gabapentinoid followed by a diuretic among older adults with lower back pain.

29 Jul, 2021 | 11:02h | UTC

Evidence of a gabapentinoid and diuretic prescribing cascade among older adults with lower back pain – Journal of the American Geriatrics Society (link to abstract – $ for full-text)

Related:

Are you the victim of a prescribing cascade?

Study: Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults with Hypertension

Prescribing Cascade in a Cardiology Practice

 


Review: Anabolic Therapy for Osteoporosis.

28 Jul, 2021 | 09:48h | UTC

Anabolic Therapy for Osteoporosis – JAMA (free for a limited period)

Author interview: Anabolic Therapy for Osteoporosis

 


Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management.

28 Jul, 2021 | 09:44h | UTC

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management – European Respiratory Review

 


The use and impact of monoclonal antibody biologics during pregnancy.

28 Jul, 2021 | 09:43h | UTC

The use and impact of monoclonal antibody biologics during pregnancy – Canadian Medical Association Journal

 


Stay Updated in Your Specialty

No spam, just news.